These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 9371228

  • 1. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas.
    Benefield J, Petruzzelli GJ, Fowler S, Taitz A, Kalkanis J, Young MR.
    Invasion Metastasis; 1996; 16(6):291-301. PubMed ID: 9371228
    [Abstract] [Full Text] [Related]

  • 2. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F, Götte K, Li M, Hörmann K, Grandis JR.
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [Abstract] [Full Text] [Related]

  • 3. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F, Götte K, Li M, Hörmann K, Grandis JR.
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
    Salven P, Heikkilä P, Anttonen A, Kajanti M, Joensuu H.
    Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
    [Abstract] [Full Text] [Related]

  • 5. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B, Bran G, Hörmann K, Riedel F.
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [Abstract] [Full Text] [Related]

  • 6. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
    Sakamoto T, Ishibashi T, Kimura H, Yoshikawa H, Spee C, Harris MS, Hinton DR, Ryan SJ.
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
    Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M.
    Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
    Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A, Burian M.
    Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY.
    Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444
    [Abstract] [Full Text] [Related]

  • 14. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F.
    Cancer Res; 2000 Apr 15; 60(8):2178-89. PubMed ID: 10786682
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck.
    Neuchrist C, Erovic BM, Handisurya A, Steiner GE, Rockwell P, Gedlicka C, Burian M.
    Laryngoscope; 2001 Oct 15; 111(10):1834-41. PubMed ID: 11801954
    [Abstract] [Full Text] [Related]

  • 16. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
    Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL.
    Arch Otolaryngol Head Neck Surg; 2003 Aug 15; 129(8):882-8. PubMed ID: 12925349
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck.
    Riedel F, Götte K, Bergler W, Hörmann K.
    Oncol Rep; 2001 Aug 15; 8(3):471-6. PubMed ID: 11295065
    [Abstract] [Full Text] [Related]

  • 20. Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferations.
    Petruzzelli GJ, Benefield J, Taitz AD, Fowler S, Kalkanis J, Scobercea S, West D, Young MR.
    Head Neck; 1997 Oct 15; 19(7):576-82. PubMed ID: 9323145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.